Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Sivik Global Healthcare Betting Big on These Five Stocks in Q4

Page 1 of 2

Sivik Global Healthcare, led by Krishen Sud, has issued its latest 13F filing with the U.S. Securities and Exchange Commission for the reporting period ended September 30, revealing an equity portfolio worth over $206 million. Greenwich, Connecticut-based Sivik Global is a healthcare-focused hedge fund that was founded by Krishen Sud in 2006. The fund had over 90% of its equity portfolio invested in the healthcare sector. In this article, we will be taking a closer look at Sivik Global’s top stocks for the third quarter.



Most investors don’t understand hedge funds and indicators that are based on hedge funds’ activities. They ignore hedge funds because of their recent poor performance in the bull market. Our research indicates that hedge funds underperformed because they aren’t 100% long. Hedge fund fees are also very large compared to the returns generated and they reduce the net returns experienced by investors. We uncovered that hedge funds’ long positions actually outperformed the market. For instance the 15 most popular small-cap stocks among funds beat the S&P 500 Index by more than 53 percentage points since the end of August 2012. These stocks returned a cumulative of 102% vs. a 48.7% gain for the S&P 500 Index (see the details here). That’s why we believe investors should pay attention to what hedge funds are buying (rather than what their net returns are).

Krishen Sud
Krishen Sud
Sivik Global Healthcare

#5 McKesson Corporation (NYSE:MCK)

Shares held (as of September 30): 45,000

Total Value (as of September 30): $8,326,000

Percent of Portfolio (as of September 30): 4.04%

Sivik Global was bullish on McKesson Corporation (NYSE:MCK) during the third quarter, with the investor boosting its position by 70%. McKesson Corporation (NYSE:MCK) is a $42.28-billion market cap healthcare services and information technology company. It posted strong financial results for the second quarter ended September 30, with revenue increasing by 10% to $48.8 billion year-over-year. Earnings per share for the quarter was $3.31, up from $2.79 a year ago. Another largest shareholder of the company among those we track is Eli Cohen’s Crescent Park Management, which holds 220,195 shares.

Follow Mckesson Corp (NYSE:MCK)
Trade (NYSE:MCK) Now!

#4 Aetna Inc (NYSE:AET)

Shares held (as of September 30): 80,000

Total Value (as of September 30): $8.75 million

Percent of Portfolio (as of September 30): 4.25%

Sivik Global upped its position in health care benefits company Aetna Inc (NYSE:AET) by around 14%. In July, Aetna Inc (NYSE:AET) signed an agreement to acquire Humana Inc (NYSE:HUM) for $37 billion. The merger was approved by shareholders of both companies last month. Under the terms of the deal, Humana stockholders will receive $125 in cash and 0.8375 share of Aetna common stock for each Humana share. The deal is expected to close in the second half of 2016. Shares of Aetna Inc (NYSE:AET)’s have gained over 20% year-to-date. Another investor that sees value in Aetna is Larry Robbins’ Glenview Capital, with ownership of around 5.57 million shares as of the end of June. Robbins also mentioned Aetna in his third-quarter investor letter.

Follow Aetna Inc (NYSE:AET)
Trade (NYSE:AET) Now!
Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!